))
This Biotech CEO Has a Unique Approach To Fight Cancer. Cel-Sci Corp CEO - $CVM
Manage episode 446210798 series 3232962
Conteúdo fornecido por Adam Sarhan. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Adam Sarhan ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
This Biotech CEO Has a Unique Approach To Fight Cancer. Cel-Sci Corp CEO - $CVM
Guest: Geert Kersten CEO of CEL SCI Corp $CVM
Ticker: $CVM
Website: https://cel-sci.com/
Geert Kersten Biography
Geert Kersten has served in his current leadership role as Chief Executive Officer at CEL-SCI Corporation (NYSE American: CVM) since 1995 and has been with CEL-SCI since 1987. He has been involved in the pioneering field of cancer immunotherapy for over three decades and has successfully steered CEL-SCI through many challenging cycles in the biotechnology industry. Mr. Kersten also provides CEL-SCI with significant expertise in the fields of finance and law and has a unique vision of how CEL-SCI's Multikine product could potentially change the way cancer is treated. Prior to joining CEL-SCI, Mr. Kersten worked at the law firm of Finley & Kumble and worked at Source Capital. Mr. Kersten received his Undergraduate Degree in Accounting and an M.B.A. from George Washington University, and a law degree (J.D.) from American University in Washington, DC.
Investors Can Learn More:
https://cel-sci.com/new-investor-information/
--- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support186 episódios
Compartilhar
